Skip to main content
Top
Published in: Intensive Care Medicine 2/2010

Open Access 01-02-2010 | Year in Review 2009

Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control

Authors: Massimo Antonelli, Elie Azoulay, Marc Bonten, Jean Chastre, Giuseppe Citerio, Giorgio Conti, Daniel De Backer, François Lemaire, Herwig Gerlach, Goran Hedenstierna, Michael Joannidis, Duncan Macrae, Jordi Mancebo, Salvatore M. Maggiore, Alexandre Mebazaa, Jean-Charles Preiser, Jerôme Pugin, Jan Wernerman, Haibo Zhang

Published in: Intensive Care Medicine | Issue 2/2010

Login to get access

Excerpt

Any delay in adequate antibiotic treatment may compromise the outcome of ventilator-associated pneumonia (VAP). However, the diagnosis and optimal treatment of VAP remain a challenge for intensivists. Jung et al. [1] assessed the potential impact of using results of once-a-week routine quantitative endotracheal aspirate (EA) cultures to guide initial antibiotic treatment in a study of 113 episodes of bronchoalveolar lavage-confirmed VAP. When guided by EA, the initial antibiotic regimen was adequate in 85% of situations, a proportion significantly superior to that resulting from application of the ATS guidelines (73%). When clinicians did not have a pre-VAP EA to guide their treatment (EA not performed group), only 61% of treatments were adequate, confirming that routine surveillance cultures may help to improve the adequacy of empiric antibiotic therapy for VAP. …
Literature
1.
go back to reference Jung B, Sebbane M, Chanques G, Courouble P, Verzilli D, Perrigault PF, Jean-Pierre H, Eledjam JJ, Jaber S (2009) Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia. Intensive Care Med 35:101–107CrossRefPubMed Jung B, Sebbane M, Chanques G, Courouble P, Verzilli D, Perrigault PF, Jean-Pierre H, Eledjam JJ, Jaber S (2009) Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia. Intensive Care Med 35:101–107CrossRefPubMed
2.
go back to reference Patman S, Jenkins S, Stiller K (2009) Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury. Intensive Care Med 35:258–265CrossRefPubMed Patman S, Jenkins S, Stiller K (2009) Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury. Intensive Care Med 35:258–265CrossRefPubMed
3.
go back to reference Martinez JA, Delgado E, Marti S, Marco F, Vila J, Mensa J, Torres A, Codina C, Trilla A, Soriano A, Alquezar A, Castro P, Nicolas JM (2009) Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med 35:439–447CrossRefPubMed Martinez JA, Delgado E, Marti S, Marco F, Vila J, Mensa J, Torres A, Codina C, Trilla A, Soriano A, Alquezar A, Castro P, Nicolas JM (2009) Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients. Intensive Care Med 35:439–447CrossRefPubMed
4.
go back to reference Rodriguez A, Lisboa T, Blot S, Martin-Loeches I, Sole-Violan J, De Mendoza D, Rello J (2009) Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 35:430–438CrossRefPubMed Rodriguez A, Lisboa T, Blot S, Martin-Loeches I, Sole-Violan J, De Mendoza D, Rello J (2009) Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med 35:430–438CrossRefPubMed
5.
go back to reference Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ (2009) Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 35:854–861CrossRefPubMed Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ (2009) Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 35:854–861CrossRefPubMed
6.
go back to reference Baldesi O, Michel F, Guervilly C, Embriaco N, Granfond A, La Scola B, Portugal H, Papazian L (2009) Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution. Intensive Care Med 35:1210–1215CrossRefPubMed Baldesi O, Michel F, Guervilly C, Embriaco N, Granfond A, La Scola B, Portugal H, Papazian L (2009) Bacterial ventilator-associated pneumonia: bronchoalveolar lavage results are not influenced by dilution. Intensive Care Med 35:1210–1215CrossRefPubMed
7.
go back to reference Oudhuis GJ, Beuving J, Bergmans D, Stobberingh EE, ten Velde G, Linssen CF, Verbon A (2009) Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 35:1265–1270CrossRefPubMed Oudhuis GJ, Beuving J, Bergmans D, Stobberingh EE, ten Velde G, Linssen CF, Verbon A (2009) Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 35:1265–1270CrossRefPubMed
8.
go back to reference Jiyong J, Tiancha H, Wei C, Huahao S (2009) Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med 35:587–595CrossRefPubMed Jiyong J, Tiancha H, Wei C, Huahao S (2009) Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med 35:587–595CrossRefPubMed
9.
go back to reference Hawe CS, Ellis KS, Cairns CJ, Longmate A (2009) Reduction of ventilator-associated pneumonia: active versus passive guideline implementation. Intensive Care Med 35:1180–1186CrossRefPubMed Hawe CS, Ellis KS, Cairns CJ, Longmate A (2009) Reduction of ventilator-associated pneumonia: active versus passive guideline implementation. Intensive Care Med 35:1180–1186CrossRefPubMed
10.
go back to reference de Smet AM, Hopmans TE, Minderhoud AL, Blok HE, Gossink-Franssen A, Bernards AT, Bonten MJ (2009) Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit. Intensive Care Med 35:1609–1613CrossRefPubMed de Smet AM, Hopmans TE, Minderhoud AL, Blok HE, Gossink-Franssen A, Bernards AT, Bonten MJ (2009) Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit. Intensive Care Med 35:1609–1613CrossRefPubMed
11.
go back to reference Hortal J, Giannella M, Perez MJ, Barrio JM, Desco M, Bouza E, Munoz P (2009) Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 35:1518–1525CrossRefPubMed Hortal J, Giannella M, Perez MJ, Barrio JM, Desco M, Bouza E, Munoz P (2009) Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 35:1518–1525CrossRefPubMed
12.
go back to reference Torres A, Ewig S, Lode H, Carlet J (2009) Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 35:9–29CrossRefPubMed Torres A, Ewig S, Lode H, Carlet J (2009) Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 35:9–29CrossRefPubMed
13.
go back to reference Torres A, Ewig S (2009) Reply to van Saene et al. Intensive Care Med 35:1817CrossRef Torres A, Ewig S (2009) Reply to van Saene et al. Intensive Care Med 35:1817CrossRef
14.
go back to reference Zandstra DF, Petros AJ, van Saene HK (2009) The final gasp from the European experts. Intensive Care Med 35:1816; author reply 1817 Zandstra DF, Petros AJ, van Saene HK (2009) The final gasp from the European experts. Intensive Care Med 35:1816; author reply 1817
15.
go back to reference Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, Molina JM, Schlemmer B, Azoulay E (2009) Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 35:1678–1686CrossRefPubMed Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, Molina JM, Schlemmer B, Azoulay E (2009) Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 35:1678–1686CrossRefPubMed
16.
go back to reference Azoulay E, Cohen Y, Zahar J-R, Garrouste-Orgeas M, Adrie C, Moine P, de Lassence A, Timsit J-F (2004) Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 30:1384–1389PubMed Azoulay E, Cohen Y, Zahar J-R, Garrouste-Orgeas M, Adrie C, Moine P, de Lassence A, Timsit J-F (2004) Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 30:1384–1389PubMed
17.
go back to reference Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E (2009) Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 35:1526–1531CrossRefPubMed Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E (2009) Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 35:1526–1531CrossRefPubMed
18.
go back to reference Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 35:55–62CrossRefPubMed Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 35:55–62CrossRefPubMed
19.
go back to reference Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med 35:206–214CrossRefPubMed Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med 35:206–214CrossRefPubMed
20.
go back to reference Hanberger H, Arman D, Gill H, Jindrak V, Kalenic S, Kurcz A, Licker M, Naaber P, Scicluna EA, Vanis V, Walther SM (2009) Surveillance of microbial resistance in European intensive care units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med 35:91–100CrossRefPubMed Hanberger H, Arman D, Gill H, Jindrak V, Kalenic S, Kurcz A, Licker M, Naaber P, Scicluna EA, Vanis V, Walther SM (2009) Surveillance of microbial resistance in European intensive care units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med 35:91–100CrossRefPubMed
21.
go back to reference Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F (2009) Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Med 35:862–870CrossRefPubMed Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F (2009) Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Med 35:862–870CrossRefPubMed
22.
go back to reference Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci MG, Mercurio G, Maggiore SM, Antonelli M (2009) Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med 35:1964–1969CrossRefPubMed Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci MG, Mercurio G, Maggiore SM, Antonelli M (2009) Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med 35:1964–1969CrossRefPubMed
23.
go back to reference Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC (2009) Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 35:2141–2145 Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC (2009) Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 35:2141–2145
24.
go back to reference Charles PE, Castro C, Ruiz-Santana S, Leon C, Saavedra P, Martin E (2009) Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 35:2146–2150 Charles PE, Castro C, Ruiz-Santana S, Leon C, Saavedra P, Martin E (2009) Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 35:2146–2150
25.
go back to reference Perez-Parra A, Munoz P, Guinea J, Martin-Rabadan P, Guembe M, Bouza E (2009) Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med 35:707–712CrossRefPubMed Perez-Parra A, Munoz P, Guinea J, Martin-Rabadan P, Guembe M, Bouza E (2009) Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med 35:707–712CrossRefPubMed
26.
go back to reference Senn L, Eggimann P, Ksontini R, Pascual A, Demartines N, Bille J, Calandra T, Marchetti O (2009) Caspofungin for prevention of intraabdominal candidiasis in high-risk surgical patients. Intensive Care Med 35:903–908CrossRefPubMed Senn L, Eggimann P, Ksontini R, Pascual A, Demartines N, Bille J, Calandra T, Marchetti O (2009) Caspofungin for prevention of intraabdominal candidiasis in high-risk surgical patients. Intensive Care Med 35:903–908CrossRefPubMed
27.
go back to reference Michalia M, Kompoti M, Koutsikou A, Paridou A, Giannopoulou P, Trikka-Graphakos E, Clouva-Molyvdas P (2009) Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med 35:448–454CrossRefPubMed Michalia M, Kompoti M, Koutsikou A, Paridou A, Giannopoulou P, Trikka-Graphakos E, Clouva-Molyvdas P (2009) Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med 35:448–454CrossRefPubMed
28.
go back to reference Karvellas CJ, Pink F, McPhail M, Cross T, Auzinger G, Bernal W, Sizer E, Kutsogiannis DJ, Eltringham I, Wendon JA (2009) Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med 35:1390–1396CrossRefPubMed Karvellas CJ, Pink F, McPhail M, Cross T, Auzinger G, Bernal W, Sizer E, Kutsogiannis DJ, Eltringham I, Wendon JA (2009) Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med 35:1390–1396CrossRefPubMed
29.
go back to reference Saayman AG, Findlay GP, Barnes RA, Wise MP (2009) Bacteraemia following single-stage percutaneous dilatational tracheostomy. Intensive Care Med 35:1970–1973CrossRefPubMed Saayman AG, Findlay GP, Barnes RA, Wise MP (2009) Bacteraemia following single-stage percutaneous dilatational tracheostomy. Intensive Care Med 35:1970–1973CrossRefPubMed
30.
go back to reference Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, Hilbert G, Gruson D (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35:847–853CrossRefPubMed Boyer A, Vargas F, Coste F, Saubusse E, Castaing Y, Gbikpi-Benissan G, Hilbert G, Gruson D (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35:847–853CrossRefPubMed
31.
go back to reference Souweine B, Lautrette A, Aumeran C, Benedit M, Constantin JM, Bonnard M, Guelon D, Amat G, Aublet B, Bonnet R, Traore O (2009) Comparison of acceptability, skin tolerance, and compliance between handwashing and alcohol-based handrub in ICUs: results of a multicentric study. Intensive Care Med 35:1216–1224CrossRefPubMed Souweine B, Lautrette A, Aumeran C, Benedit M, Constantin JM, Bonnard M, Guelon D, Amat G, Aublet B, Bonnet R, Traore O (2009) Comparison of acceptability, skin tolerance, and compliance between handwashing and alcohol-based handrub in ICUs: results of a multicentric study. Intensive Care Med 35:1216–1224CrossRefPubMed
32.
go back to reference Silvestre J, Povoa P, Coelho L, Almeida E, Moreira P, Fernandes A, Mealha R, Sabino H (2009) Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35:909–913CrossRefPubMed Silvestre J, Povoa P, Coelho L, Almeida E, Moreira P, Fernandes A, Mealha R, Sabino H (2009) Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35:909–913CrossRefPubMed
33.
go back to reference Manzanares W, Biestro A, Galusso F, Torre MH, Manay N, Pittini G, Facchin G, Hardy G (2009) Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill? Intensive Care Med 35:882–889CrossRefPubMed Manzanares W, Biestro A, Galusso F, Torre MH, Manay N, Pittini G, Facchin G, Hardy G (2009) Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill? Intensive Care Med 35:882–889CrossRefPubMed
34.
go back to reference Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohe J, Lepape A, Monneret G (2009) Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 35:1859–1867CrossRefPubMed Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohe J, Lepape A, Monneret G (2009) Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med 35:1859–1867CrossRefPubMed
35.
go back to reference Berg RM, Strauss GI, Tofteng F, Qvist T, Edvinsson L, Fahrenkrug J, Qvist J, Fonsmark L, Skinhoj P, Moller K (2009) Circulating levels of vasoactive peptides in patients with acute bacterial meningitis. Intensive Care Med 35:1604–1608CrossRefPubMed Berg RM, Strauss GI, Tofteng F, Qvist T, Edvinsson L, Fahrenkrug J, Qvist J, Fonsmark L, Skinhoj P, Moller K (2009) Circulating levels of vasoactive peptides in patients with acute bacterial meningitis. Intensive Care Med 35:1604–1608CrossRefPubMed
36.
go back to reference van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB (2009) Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 35:1567–1574CrossRefPubMed van der Heijden M, Pickkers P, van Nieuw Amerongen GP, van Hinsbergh VW, Bouw MP, van der Hoeven JG, Groeneveld AB (2009) Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 35:1567–1574CrossRefPubMed
37.
go back to reference Barlage S, Gnewuch C, Liebisch G, Wolf Z, Audebert FX, Gluck T, Frohlich D, Kramer BK, Rothe G, Schmitz G (2009) Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med 35:1877–1885CrossRefPubMed Barlage S, Gnewuch C, Liebisch G, Wolf Z, Audebert FX, Gluck T, Frohlich D, Kramer BK, Rothe G, Schmitz G (2009) Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med 35:1877–1885CrossRefPubMed
38.
go back to reference Su L, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, Thompson BT, Christiani DC (2009) Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med 35:1024–1030CrossRefPubMed Su L, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, Thompson BT, Christiani DC (2009) Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med 35:1024–1030CrossRefPubMed
39.
go back to reference Takaki S, Takeyama N, Kajita Y, Yabuki T, Noguchi H, Miki Y, Inoue Y, Nakagawa T (2009) Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock. Intensive Care Med. doi:10.1007/s00134-009-1575-4 Takaki S, Takeyama N, Kajita Y, Yabuki T, Noguchi H, Miki Y, Inoue Y, Nakagawa T (2009) Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shock. Intensive Care Med. doi:10.​1007/​s00134-009-1575-4
40.
go back to reference Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, Holzinger U, Schenk P, Madl C (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397–1405CrossRefPubMed Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, Holzinger U, Schenk P, Madl C (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397–1405CrossRefPubMed
41.
go back to reference Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) ‘Liver function tests’ on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406–1411CrossRefPubMed Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) ‘Liver function tests’ on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406–1411CrossRefPubMed
42.
go back to reference Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M (2009) A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med 35:717–721CrossRefPubMed Kruger PS, Freir NM, Venkatesh B, Robertson TA, Roberts MS, Jones M (2009) A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. Intensive Care Med 35:717–721CrossRefPubMed
43.
go back to reference Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y (2009) The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med 35:1255–1260CrossRefPubMed Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y (2009) The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med 35:1255–1260CrossRefPubMed
44.
go back to reference Vieillard-Baron A, Caille V, Charron C, Belliard G, Aegerter P, Page B, Jardin F (2009) Reversal of refractory septic shock with drotrecogin alpha (activated). Intensive Care Med 35:1204–1209CrossRefPubMed Vieillard-Baron A, Caille V, Charron C, Belliard G, Aegerter P, Page B, Jardin F (2009) Reversal of refractory septic shock with drotrecogin alpha (activated). Intensive Care Med 35:1204–1209CrossRefPubMed
45.
go back to reference Dhainaut JF, Antonelli M, Wright P, Desachy A, Reignier J, Lavoue S, Charpentier J, Belger M, Cobas-Meyer M, Maier C, Mignini MA, Janes J (2009) Extended drotrecogin alpha (activated) treatment in patients with prolonged septic shock. Intensive Care Med 35:1187–1195CrossRefPubMed Dhainaut JF, Antonelli M, Wright P, Desachy A, Reignier J, Lavoue S, Charpentier J, Belger M, Cobas-Meyer M, Maier C, Mignini MA, Janes J (2009) Extended drotrecogin alpha (activated) treatment in patients with prolonged septic shock. Intensive Care Med 35:1187–1195CrossRefPubMed
46.
go back to reference Levy M, Levi M, Williams MD, Antonelli M, Wang D, Mignini MA (2009) Comprehensive safety analysis of concomitant drotrecogin alpha (activated) and prophylactic heparin use in patients with severe sepsis. Intensive Care Med 35:1196–1203CrossRefPubMed Levy M, Levi M, Williams MD, Antonelli M, Wang D, Mignini MA (2009) Comprehensive safety analysis of concomitant drotrecogin alpha (activated) and prophylactic heparin use in patients with severe sepsis. Intensive Care Med 35:1196–1203CrossRefPubMed
47.
go back to reference Crivellari M, Della Valle P, Landoni G, Pappalardo F, Gerli C, Bignami E, Marino G, Zangrillo A, D’Angelo A (2009) Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery. Intensive Care Med 35:1959–1963CrossRefPubMed Crivellari M, Della Valle P, Landoni G, Pappalardo F, Gerli C, Bignami E, Marino G, Zangrillo A, D’Angelo A (2009) Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery. Intensive Care Med 35:1959–1963CrossRefPubMed
48.
go back to reference Prat G, Lefevre M, Nowak E, Tonnelier JM, Renault A, L’Her E, Boles JM (2009) Impact of clinical guidelines to improve appropriateness of laboratory tests and chest radiographs. Intensive Care Med 35:1047–1053CrossRefPubMed Prat G, Lefevre M, Nowak E, Tonnelier JM, Renault A, L’Her E, Boles JM (2009) Impact of clinical guidelines to improve appropriateness of laboratory tests and chest radiographs. Intensive Care Med 35:1047–1053CrossRefPubMed
49.
go back to reference Briegel J, Sprung CL, Annane D, Singer M, Keh D, Moreno R, Mohnle P, Weiss Y, Avidan A, Brunkhorst FM, Fiedler F, Vogeser M (2009) Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med 35:2151–2156 Briegel J, Sprung CL, Annane D, Singer M, Keh D, Moreno R, Mohnle P, Weiss Y, Avidan A, Brunkhorst FM, Fiedler F, Vogeser M (2009) Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med 35:2151–2156
50.
go back to reference Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Reinhart K, Singer M, Payen D, Weiss YG (2009) The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 35:1868–1876CrossRefPubMed Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Reinhart K, Singer M, Payen D, Weiss YG (2009) The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 35:1868–1876CrossRefPubMed
51.
go back to reference Riutta A, Ylitalo P, Kaukinen S (2009) Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients. Intensive Care Med 35:1720–1727CrossRefPubMed Riutta A, Ylitalo P, Kaukinen S (2009) Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients. Intensive Care Med 35:1720–1727CrossRefPubMed
52.
go back to reference Hogue CW Jr, Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, Pronovost PJ, Needham DM (2009) The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 35:1152–1170CrossRefPubMed Hogue CW Jr, Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, Pronovost PJ, Needham DM (2009) The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 35:1152–1170CrossRefPubMed
53.
go back to reference Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M (2009) Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 35:826–832CrossRefPubMed Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M (2009) Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 35:826–832CrossRefPubMed
54.
go back to reference Buschmann CT, Tsokos M (2009) Frequent and rare complications of resuscitation attempts. Intensive Care Med 35:397–404CrossRefPubMed Buschmann CT, Tsokos M (2009) Frequent and rare complications of resuscitation attempts. Intensive Care Med 35:397–404CrossRefPubMed
55.
go back to reference Wright SE, Lochan R, Imrie K, Baker C, Nesbitt ID, Kilner AJ, Charnley RM (2009) Quality of life and functional outcome at 3, 6 and 12 months after acute necrotising pancreatitis. Intensive Care Med 35:1974–1978CrossRefPubMed Wright SE, Lochan R, Imrie K, Baker C, Nesbitt ID, Kilner AJ, Charnley RM (2009) Quality of life and functional outcome at 3, 6 and 12 months after acute necrotising pancreatitis. Intensive Care Med 35:1974–1978CrossRefPubMed
56.
go back to reference Iribarren-Diarasarri S, Aizpuru-Barandiaran F, Munoz-Martinez T, Loma-Osorio A, Hernandez-Lopez M, Ruiz-Zorrilla JM, Castillo-Arenal C, Dudagoitia-Otaolea JL, Martinez-Alutiz S, Vinuesa-Lozano C (2009) Health-related quality of life as a prognostic factor of survival in critically ill patients. Intensive Care Med 35:833–839CrossRefPubMed Iribarren-Diarasarri S, Aizpuru-Barandiaran F, Munoz-Martinez T, Loma-Osorio A, Hernandez-Lopez M, Ruiz-Zorrilla JM, Castillo-Arenal C, Dudagoitia-Otaolea JL, Martinez-Alutiz S, Vinuesa-Lozano C (2009) Health-related quality of life as a prognostic factor of survival in critically ill patients. Intensive Care Med 35:833–839CrossRefPubMed
57.
go back to reference Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall J-R (2005) SAPS 3? From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31:1345–1355CrossRefPubMed Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall J-R (2005) SAPS 3? From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31:1345–1355CrossRefPubMed
58.
go back to reference Poole D, Rossi C, Anghileri A, Giardino M, Latronico N, Radrizzani D, Langer M, Bertolini G (2009) External validation of the Simplified Acute Physiology Score (SAPS) 3 in a cohort of 28,357 patients from 147 Italian intensive care units. Intensive Care Med 35:1916–1924CrossRefPubMed Poole D, Rossi C, Anghileri A, Giardino M, Latronico N, Radrizzani D, Langer M, Bertolini G (2009) External validation of the Simplified Acute Physiology Score (SAPS) 3 in a cohort of 28,357 patients from 147 Italian intensive care units. Intensive Care Med 35:1916–1924CrossRefPubMed
59.
go back to reference Ledoux D, Canivet JL, Preiser JC, Lefrancq J, Damas P (2008) SAPS 3 admission score: an external validation in a general intensive care population. Intensive Care Med 34:1873–1877CrossRefPubMed Ledoux D, Canivet JL, Preiser JC, Lefrancq J, Damas P (2008) SAPS 3 admission score: an external validation in a general intensive care population. Intensive Care Med 34:1873–1877CrossRefPubMed
60.
go back to reference Metnitz B, Schaden E, Moreno R, Le Gall JR, Bauer P, Metnitz PG (2009) Austrian validation and customization of the SAPS 3 admission score. Intensive Care Med 35:616–622CrossRefPubMed Metnitz B, Schaden E, Moreno R, Le Gall JR, Bauer P, Metnitz PG (2009) Austrian validation and customization of the SAPS 3 admission score. Intensive Care Med 35:616–622CrossRefPubMed
61.
go back to reference Azoulay E, Metnitz B, Sprung CL, Timsit JF, Lemaire F, Bauer P, Schlemmer B, Moreno R, Metnitz P (2009) End-of-life practices in 282 intensive care units: data from the SAPS 3 database. Intensive Care Med 35:623–630CrossRefPubMed Azoulay E, Metnitz B, Sprung CL, Timsit JF, Lemaire F, Bauer P, Schlemmer B, Moreno R, Metnitz P (2009) End-of-life practices in 282 intensive care units: data from the SAPS 3 database. Intensive Care Med 35:623–630CrossRefPubMed
62.
go back to reference Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518CrossRefPubMed Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512–518CrossRefPubMed
63.
go back to reference Herbland A, El Zein I, Valentino R, Cassinotto C, Meunier C, Rieux D, Mehdaoui H (2009) Star fruit poisoning is potentially life-threatening in patients with moderate chronic renal failure. Intensive Care Med 35:1459–1463CrossRefPubMed Herbland A, El Zein I, Valentino R, Cassinotto C, Meunier C, Rieux D, Mehdaoui H (2009) Star fruit poisoning is potentially life-threatening in patients with moderate chronic renal failure. Intensive Care Med 35:1459–1463CrossRefPubMed
64.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 8:R204–R212CrossRefPubMed Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 8:R204–R212CrossRefPubMed
65.
go back to reference Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMed Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMed
66.
go back to reference Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35:1692–1702CrossRefPubMed Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35:1692–1702CrossRefPubMed
67.
go back to reference Joannidis M, Metnitz PG (2005) Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 21:239–249CrossRefPubMed Joannidis M, Metnitz PG (2005) Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 21:239–249CrossRefPubMed
68.
go back to reference Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881CrossRefPubMed Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881CrossRefPubMed
69.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596CrossRefPubMed Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596CrossRefPubMed
70.
go back to reference Cartin-Ceba R, Haugen EN, Iscimen R, Trillo-Alvarez C, Juncos L, Gajic O (2009) Evaluation of “loss” and “end stage renal disease” after acute kidney injury defined by the risk, injury, failure, loss and ESRD classification in critically ill patients. Intensive Care Med 35:2087–2095 Cartin-Ceba R, Haugen EN, Iscimen R, Trillo-Alvarez C, Juncos L, Gajic O (2009) Evaluation of “loss” and “end stage renal disease” after acute kidney injury defined by the risk, injury, failure, loss and ESRD classification in critically ill patients. Intensive Care Med 35:2087–2095
71.
go back to reference Delannoy B, Floccard B, Thiolliere F, Kaaki M, Badet M, Rosselli S, Ber CE, Saez A, Flandreau G, Guerin C (2009) Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study. Intensive Care Med 35:1907–1915CrossRefPubMed Delannoy B, Floccard B, Thiolliere F, Kaaki M, Badet M, Rosselli S, Ber CE, Saez A, Flandreau G, Guerin C (2009) Six-month outcome in acute kidney injury requiring renal replacement therapy in the ICU: a multicentre prospective study. Intensive Care Med 35:1907–1915CrossRefPubMed
72.
go back to reference Redfors B, Sward K, Sellgren J, Ricksten SE (2009) Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 35:115–122CrossRefPubMed Redfors B, Sward K, Sellgren J, Ricksten SE (2009) Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery. Intensive Care Med 35:115–122CrossRefPubMed
73.
go back to reference Umgelter A, Reindl W, Franzen M, Lenhardt C, Huber W, Schmid RM (2009) Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites. Intensive Care Med 35:152–156CrossRefPubMed Umgelter A, Reindl W, Franzen M, Lenhardt C, Huber W, Schmid RM (2009) Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites. Intensive Care Med 35:152–156CrossRefPubMed
74.
go back to reference Darmon M, Schortgen F, Leon R, Moutereau S, Mayaux J, Di Marco F, Devaquet J, Brun-Buisson C, Brochard L (2009) Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation. Intensive Care Med 35:1031–1038CrossRefPubMed Darmon M, Schortgen F, Leon R, Moutereau S, Mayaux J, Di Marco F, Devaquet J, Brun-Buisson C, Brochard L (2009) Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation. Intensive Care Med 35:1031–1038CrossRefPubMed
75.
go back to reference Doberer D, Funk GC, Kirchner K, Schneeweiss B (2009) A critique of Stewart’s approach: the chemical mechanism of dilutional acidosis. Intensive Care Med 35:2173–2180 Doberer D, Funk GC, Kirchner K, Schneeweiss B (2009) A critique of Stewart’s approach: the chemical mechanism of dilutional acidosis. Intensive Care Med 35:2173–2180
76.
go back to reference Gattinoni L, Carlesso E, Maiocchi G, Polli F, Cadringher P (2009) Dilutional acidosis: where do the protons come from? Intensive Care Med 35:2033–2043 Gattinoni L, Carlesso E, Maiocchi G, Polli F, Cadringher P (2009) Dilutional acidosis: where do the protons come from? Intensive Care Med 35:2033–2043
77.
go back to reference Davenport A (2009) Dilutional acidosis or uncovered cellular metabolism? Intensive Care Med 35:2009–2011 Davenport A (2009) Dilutional acidosis or uncovered cellular metabolism? Intensive Care Med 35:2009–2011
78.
go back to reference Gatz R (2009) The Stewart approach to acid-base analysis: not disqualified yet. Intensive Care Med 35:2181–2182 Gatz R (2009) The Stewart approach to acid-base analysis: not disqualified yet. Intensive Care Med 35:2181–2182
79.
go back to reference Ring T (2009) Mixing bicarbonates: dilution acidosis from first principles. Intensive Care Med 35:2183–2184 Ring T (2009) Mixing bicarbonates: dilution acidosis from first principles. Intensive Care Med 35:2183–2184
80.
go back to reference Zanella A, Patroniti N, Isgro S, Albertini M, Costanzi M, Pirrone F, Scaravilli V, Vergnano B, Pesenti A (2009) Blood acidification enhances carbon dioxide removal of membrane lung: an experimental study. Intensive Care Med 35:1484–1487CrossRefPubMed Zanella A, Patroniti N, Isgro S, Albertini M, Costanzi M, Pirrone F, Scaravilli V, Vergnano B, Pesenti A (2009) Blood acidification enhances carbon dioxide removal of membrane lung: an experimental study. Intensive Care Med 35:1484–1487CrossRefPubMed
81.
go back to reference Fencl V, Jabor A, Kazda A, Figge J (2000) Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med 162:2246–2251PubMed Fencl V, Jabor A, Kazda A, Figge J (2000) Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med 162:2246–2251PubMed
82.
go back to reference Boniatti MM, Cardoso PR, Castilho RK, Vieira SR (2009) Acid-base disorders evaluation in critically ill patients: we can improve our diagnostic ability. Intensive Care Med 35:1377–1382CrossRefPubMed Boniatti MM, Cardoso PR, Castilho RK, Vieira SR (2009) Acid-base disorders evaluation in critically ill patients: we can improve our diagnostic ability. Intensive Care Med 35:1377–1382CrossRefPubMed
83.
go back to reference Funk GC, Doberer D, Sterz F, Richling N, Kneidinger N, Lindner G, Schneeweiss B, Eisenburger P (2009) The strong ion gap and outcome after cardiac arrest in patients treated with therapeutic hypothermia: a retrospective study. Intensive Care Med 35:232–239CrossRefPubMed Funk GC, Doberer D, Sterz F, Richling N, Kneidinger N, Lindner G, Schneeweiss B, Eisenburger P (2009) The strong ion gap and outcome after cardiac arrest in patients treated with therapeutic hypothermia: a retrospective study. Intensive Care Med 35:232–239CrossRefPubMed
84.
go back to reference Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK (2009) The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 35:1728–1737CrossRefPubMed Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland DK (2009) The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 35:1728–1737CrossRefPubMed
85.
go back to reference Rauch S, Krueger K, Turan A, Roewer N, Sessler DI (2009) Determining small intestinal transit time and pathomorphology in critically ill patients using video capsule technology. Intensive Care Med 35:1054–1059CrossRefPubMed Rauch S, Krueger K, Turan A, Roewer N, Sessler DI (2009) Determining small intestinal transit time and pathomorphology in critically ill patients using video capsule technology. Intensive Care Med 35:1054–1059CrossRefPubMed
86.
go back to reference Holzinger U, Kitzberger R, Bojic A, Wewalka M, Miehsler W, Staudinger T, Madl C (2009) Comparison of a new unguided self-advancing jejunal tube with the endoscopic guided technique: a prospective, randomized study. Intensive Care Med 35:1614–1618CrossRefPubMed Holzinger U, Kitzberger R, Bojic A, Wewalka M, Miehsler W, Staudinger T, Madl C (2009) Comparison of a new unguided self-advancing jejunal tube with the endoscopic guided technique: a prospective, randomized study. Intensive Care Med 35:1614–1618CrossRefPubMed
87.
go back to reference Ward MM, McEwen AM, Robbins PM, Bennett MJ (2009) A simple aspiration test to determine the accuracy of oesophageal placement of fine-bore feeding tubes. Intensive Care Med 35:722–724CrossRefPubMed Ward MM, McEwen AM, Robbins PM, Bennett MJ (2009) A simple aspiration test to determine the accuracy of oesophageal placement of fine-bore feeding tubes. Intensive Care Med 35:722–724CrossRefPubMed
88.
go back to reference Doig GS, Heighes PT, Simpson F, Sweetman EA, Davies AR (2009) Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 35:2018–2027 Doig GS, Heighes PT, Simpson F, Sweetman EA, Davies AR (2009) Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 35:2018–2027
89.
go back to reference Kreutziger J, Wenzel V, Kurz A, Constantinescu MA (2009) Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients. Intensive Care Med 35:1234–1239CrossRefPubMed Kreutziger J, Wenzel V, Kurz A, Constantinescu MA (2009) Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients. Intensive Care Med 35:1234–1239CrossRefPubMed
90.
go back to reference Cordingley JJ, Vlasselaers D, Dormand NC, Wouters PJ, Squire SD, Chassin LJ, Wilinska ME, Morgan CJ, Hovorka R, Van den Berghe G (2009) Intensive insulin therapy: enhanced model predictive control algorithm versus standard care. Intensive Care Med 35:123–128CrossRefPubMed Cordingley JJ, Vlasselaers D, Dormand NC, Wouters PJ, Squire SD, Chassin LJ, Wilinska ME, Morgan CJ, Hovorka R, Van den Berghe G (2009) Intensive insulin therapy: enhanced model predictive control algorithm versus standard care. Intensive Care Med 35:123–128CrossRefPubMed
91.
go back to reference Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C (2009) Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med 35:1383–1389CrossRefPubMed Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C (2009) Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med 35:1383–1389CrossRefPubMed
92.
go back to reference Eslami S, Abu-Hanna A, de Jonge E, de Keizer NF (2009) Tight glycemic control and computerized decision-support systems: a systematic review. Intensive Care Med 35:1505–1517CrossRefPubMed Eslami S, Abu-Hanna A, de Jonge E, de Keizer NF (2009) Tight glycemic control and computerized decision-support systems: a systematic review. Intensive Care Med 35:1505–1517CrossRefPubMed
Metadata
Title
Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control
Authors
Massimo Antonelli
Elie Azoulay
Marc Bonten
Jean Chastre
Giuseppe Citerio
Giorgio Conti
Daniel De Backer
François Lemaire
Herwig Gerlach
Goran Hedenstierna
Michael Joannidis
Duncan Macrae
Jordi Mancebo
Salvatore M. Maggiore
Alexandre Mebazaa
Jean-Charles Preiser
Jerôme Pugin
Jan Wernerman
Haibo Zhang
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 2/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-009-1742-7

Other articles of this Issue 2/2010

Intensive Care Medicine 2/2010 Go to the issue